25.3 months) which did not reach statistical significance [hazard ratio (HR) 0.81, 95% CI: 0.67 to 0.99; P=0.0198].
← all excerpts
KEYNOTE-585: disappointing results for perioperative pembrolizumab in gastric cancer.
1
0.0198
0.0198
25.3 months) which did not reach statistical significance [hazard ratio (HR) 0.81, 95% CI: 0.67 to 0.99; P=0.0198].